Use of Ephedra-containing products and risk for hemorrhagic stroke: Reply from the Authors

Neurology

Volumn 61, Issue 5, 2003, Pages 725-

  Kernan, W N ^a   Brass, L M ^a   Viscoli, C M ^a   Broderick, J P ^a   Brott, T ^a   Feldmann, E ^a   Wilterdink, J L ^a   Morgenstern, L M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85026181669     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Morgenstern MD, Viscoli CM, Kernan WN, et al. Use of Ephedra-containing products and risk for hemorrhagic stroke. Neurology 2003; 60: 132-135.
2. Haller CA, Jacob P 3rd, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther 2002; 71: 411-413.
3. Arciero PJ, Gardner AW, Benowitz NL, Poehlman ET. Relationship of blood pressure, heart rate and behavioral mood state to norepinephrine kinetics in younger and older men following caffeine ingestion. Eur J Clin Nutr 1998; 52: 805-812.
4. De Matteis R, Arch JR, Petroni ML, Ferrari D, Cinti S, Stock MJ. Immunohistochemical identification of the beta(3)-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. Int J Obes Relat Metab Disord 2002; 26: 1442-1450.
5. Kalman D, Incledon TA, Gaunaurd I, Schwartz H, Krieger D. An acute clinical trial evaluating the cardiovascular effects of an herbal Ephedra-caffeine weight loss product in healthy overweight adults. Int J Obes Relat Metab Disord 2002; 26: 1363-1366.
6. Harrington DM. Hormone replacement therapy and heart disease. Replacing dogma with data. Circulation 2003; 107: 2-4.
7. Hoffman BB, Lelkowitz RJ. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, eds. Goodman & Gilman’s the pharmacological basis of therapeutics. New York: McGraw-Hill, 2001; 237.
8. White LM, Gardner SF, Gurley BJ, Marx MA, Wang P-L, Estes M. Pharmacokinetics and cardiovascular effects of Ma-Huang (Ephedra sinca) in normotensive adults. J Clin Pharmacol 1997; 37: 116-122.